Navigation Links
Arthritis and the Wnt Factor

An article by Nakamura et al., "Expression profiles and functional analyses of Wnt-related genes// in human joint disorders," will appear in the July issue of The American Journal of Pathology. The article revolves around the protein, Wnt. Wnt is a proto-oncogene since its disruption can lead to cancer in various organs. But current evidence might show that it is also involved in arthritic joint disease.

At present a through analysis of the Wnt gene family has been pending towards the progression of arthritis. A group of researchers at Shinshu University in Nagano, Japan have examined 19 members of the Wnt gene family. There study is to find out which gene is involved in arthritic joint disease. The study is being performed under the supervision of the assistant professor at the Department of Orthopedic Surgery, Dr, Shingeyuki Wakitani. The study also includes examination of joint tissues from patients who have undergone total knee replacements for rheumatoid arthritis (RA), osteoarthritis (OA), or non-arthritic injury.

The group had identified certain genes, which were upregulated in the arthritic knee tissues. These were Wnt-7b and Wnt –10a. The above was found with molecular methods, while protein expression studies reveal that only Wnt-7b was produced in arthritic joints, with strong protein localization to the synovium (or joint lining) and weak localization to cartilage and bone.

The author also examines whether inflammatory cytokines were produced in primary cartilage and synovial cells from arthritic versus normal joints. While OA cells did not differ from controls, primary RA cells produced TNF-a, IL-1? and IL-6 at levels 2- to 4-fold above controls. Importantly, this effect could be replicated in normal cells when they were engineered to express Wnt-7b, demonstrating the importance of Wnt-7b in the inflammatory response of RA.

Wnt-7b was noticed to be strongly upregulated within joints at sites of disease manifest ation mainly in synovium of RA but in synovium, cartilage, osteophyte, and bone of OA. Also findings show that Wnt-7b was recurrently found at sites of inflammation and elicited an inflammatory response, which are consistent with inflammation as a hallmark of RA disease.

This identifies Wnt-7b processing a role in arthritic processes. Arthritic diseases are known to manifest differently depending on the type, with RA displaying inflammation to the synovium and loss of cartilage and bone, and OA exhibiting a narrowing of joint space, loss of protective cartilage, and growth of bone cysts.
'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis Drug May Cause Liver Damage
7. Arthritis drug can prolong life
8. New treatment for Rheumatoid Arthritis
9. Important cause of Arthritis
10. Personality Impacts Arthritis
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking ... registration today for its 33rd Annual Issues & Research Conference, March 2-3, ... theme of the conference is “Persistent Challenges and New Opportunities: Using Research to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , a ... other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to ... president of sales. , Litsinger joined Mirixa in 2008 after serving as ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The ... ultimate weight loss and wellness program, at their world headquarters of Omni La Costa ... and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, or ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is in flux. The ... for the mass media launching of story movements to highlight what's most unfair ... unfortunate experiences; such a movement can generate the network power to improve healthcare ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)...   TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
Breaking Medicine Technology: